AU4922400A - Means and methods for altering the functional properties in eukaryotic cells - Google Patents

Means and methods for altering the functional properties in eukaryotic cells

Info

Publication number
AU4922400A
AU4922400A AU49224/00A AU4922400A AU4922400A AU 4922400 A AU4922400 A AU 4922400A AU 49224/00 A AU49224/00 A AU 49224/00A AU 4922400 A AU4922400 A AU 4922400A AU 4922400 A AU4922400 A AU 4922400A
Authority
AU
Australia
Prior art keywords
altering
methods
eukaryotic cells
functional properties
functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49224/00A
Inventor
Stefan Bonne
Frans Van Roy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vlaams Instituut voor Biotechnologie VIB
Original Assignee
Vlaams Instituut voor Biotechnologie VIB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Instituut voor Biotechnologie VIB filed Critical Vlaams Instituut voor Biotechnologie VIB
Publication of AU4922400A publication Critical patent/AU4922400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AU49224/00A 1999-04-30 2000-04-28 Means and methods for altering the functional properties in eukaryotic cells Abandoned AU4922400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99870093 1999-04-30
EP99870093 1999-04-30
PCT/EP2000/004389 WO2000066619A2 (en) 1999-04-30 2000-04-28 Means and methods for altering the functional properties in eukaryotic cells

Publications (1)

Publication Number Publication Date
AU4922400A true AU4922400A (en) 2000-11-17

Family

ID=8243831

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49224/00A Abandoned AU4922400A (en) 1999-04-30 2000-04-28 Means and methods for altering the functional properties in eukaryotic cells

Country Status (2)

Country Link
AU (1) AU4922400A (en)
WO (1) WO2000066619A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006043692A1 (en) * 2004-10-19 2006-04-27 Oncotherapy Science, Inc. Pkp3 oncogene as a prognostic indicator for lung cancer

Also Published As

Publication number Publication date
WO2000066619A3 (en) 2001-03-01
WO2000066619A2 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
AU4353200A (en) Methods and compositions for conducting processes in microfluidic devices
AU2002225681A1 (en) Yeast-dentritic cell vaccines and uses thereof
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU2002322211A1 (en) Methods and compisitions for activation human t cells in vitro
AU3731400A (en) Methods and compositions useful in inhibiting apoptosis
AU3862600A (en) Multifonctional laminate structure and process
AU2001251137A1 (en) Methods and products for regulating cell motility
AUPP995799A0 (en) Improvements in hinges
AU2841801A (en) Triazolotriazinones and the use thereof
AUPP826099A0 (en) Improvements in energy storage systems
AU6385600A (en) Interconnect assemblies and methods
AU1083501A (en) Antibiotic-metal complex and methods
AU7039400A (en) Solid soap with connecting and keeping means
AU2346800A (en) Compositions and methods using cell fusion
AU4771600A (en) Cells, culture methods and their uses
AU4706199A (en) Compositions and methods for inducing apoptosis in e6-expressing cells
AU4922400A (en) Means and methods for altering the functional properties in eukaryotic cells
AU3676900A (en) Safety device for enclosed cell and enclosed cell comprising the same
AU5979300A (en) Angiopoietin-6 and uses thereof
AU2669201A (en) Taccalonolides and their use
AU6320200A (en) Safety device for closed cell and closed cell comprising the same
AU4026900A (en) Polyurethane foam cell opening agents and methods for making foam using the same
AU5011400A (en) Molecular interactions in t cells
AU2612000A (en) Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells
AU2928300A (en) Improvements in vehicles

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase